EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Establishment of a Vancomycin Population Pharmacokinetic Model for Pediatric Patients Based on the Non-Linear Mixed-Effects Model

Biao Yu, Kangkang Mei, Didi Zhan, Qi Tang, Heping Cai, Runcong Zhang

Drugs in R&D · 2025

DOI: 10.1007/s40268-025-00523-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drugs in R&D, 2025. Verfasst von Biao Yu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Anhui Provincial Children's Hospital, No.39, Wangjiang East Road, Hefei, Anhui, China. Hauptthemen laut MEDLINE: Vancomycin, Anti-Bacterial Agents, Models, Biological. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND OBJECTIVES: Vancomycin (VCM) pharmacokinetic parameters vary widely between individuals. Existing models developed domestically and internationally may not apply universally because of differences in patient populations and testing methodologies. Therefore, the present study aimed to address the clinical challenge of optimizing individualized VCM dosing in pediatric patients at the study institution by developing a VCM population pharmacokinetic model and identifying key factors influencing VCM clearance, thereby providing a reference for safe and effective clinical dosing strategies. METHODS: Data regarding 124 effective VCM concentrations and 100 pediatric patients who received intravenous VCM were retrospectively collected. We used a non-linear mixed-effects model with forward inclusion and backward elimination to create the final VCM population pharmacokinetic model. The model was internally validated using bootstrapping, goodness of fit, and visual predictive check. The Monte Carlo method was used to simulate the range of trough concentrations in pediatric patients with renal insufficiency and normal function under different dosing regimens. RESULTS: A one-compartment model adequately described the pharmacokinetic behavior of VCM in vivo. The typical values of clearance and volume of distribution were 8.22 L/h and 113 L, respectively. Renal function and body weight were the most important factors affecting the clearance of VCM. The model was validated as stable and reliable. CONCLUSIONS: The VCM population pharmacokinetic model established during this study can assist physicians with the development and optimization of dosing regimens for pediatric patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VancomycinAnti-Bacterial AgentsModels, BiologicalHumansChildMaleFemaleRetrospective StudiesChild, PreschoolInfantNonlinear DynamicsAdolescentMonte Carlo MethodBody Weight

Substanzen

VancomycinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Pharmacy, Anhui Provincial Children's Hospital, No.39, Wangjiang East Road, Hefei, Anhui, China.
  • Department of Pharmacy, Anhui Provincial Children's Hospital, No.39, Wangjiang East Road, Hefei, Anhui, China. greenhprui@163.com.
  • Department of Pharmacy, Changxing People's Hospital, Changxing, China.

Zitieren

APA

Yu, B., Mei, K., Zhan, D., Tang, Q., Cai, H., & Zhang, R. (2025). Establishment of a Vancomycin Population Pharmacokinetic Model for Pediatric Patients Based on the Non-Linear Mixed-Effects Model. Drugs in R&D. https://doi.org/10.1007/s40268-025-00523-8

Vancouver

Yu B, Mei K, Zhan D, Tang Q, Cai H, Zhang R. Establishment of a Vancomycin Population Pharmacokinetic Model for Pediatric Patients Based on the Non-Linear Mixed-Effects Model. Drugs in R&D. 2025. doi:10.1007/s40268-025-00523-8

BibTeX
@article{Yu2025,
  author = {Yu, Biao and Mei, Kangkang and Zhan, Didi and Tang, Qi and Cai, Heping and Zhang, Runcong},
  title = {Establishment of a Vancomycin Population Pharmacokinetic Model for Pediatric Patients Based on the Non-Linear Mixed-Effects Model},
  journal = {Drugs in R&D},
  year = {2025},
  doi = {10.1007/s40268-025-00523-8}
}
Kostenlos starten →